Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | PI4KA | P42356 | 4/20 | 0.61 |
| ▸ | PI4K2B | Q8TCG2 | 4/20 | 0.61 |
| ▸ | PI4K2A | Q9BTU6 | 4/20 | 0.61 |
| ▸ | PI4KB | Q9UBF8 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | APEX1 | P27695 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | ADCY1 | Q08828 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31569297 | 0.84 | CYP2C19 (0.74) | CYP2C19PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL4572213 | 0.84 | CYP2C19 (0.74) | CYP2C19PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL17017087 | 0.82 | CYP2C19 (0.61) | CYP2C19PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL27920376 | 0.82 | NPC1 (0.69) | CYP2C19PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL9885102 | 0.81 | NPC1 (0.71) | CYP2C19PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL12844563 | 0.81 | ADORA2A (0.61) | CYP2C19PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL2876046 | 0.80 | CYP2C19 (0.68) | CYP2C19PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL219612 | 0.80 | CYP2C19 (0.68) | CYP2C19PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL1324553 | 0.80 | CYP2C19 (0.72) | CYP2C19PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL675830 | 0.80 | PI4KA (0.92) | CYP2C19PI4KAPI4K2BPI4K2API4KB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8193182-B2 | Substituted isoquinolin-1(2H)-ones, and methods of use thereof | INTELLIKINE, INC. (US) | 2012-06-05 | — | — | US | disclosed |
| US-7902373-B2 | asthma; for treating prostaglandin D2 mediated diseases; e.g. 6-(3-fluorophenyl)-N-[1-(1-methyl-1H-tetrazol-5-yl)piperidin-4-yl]nicotinamide | PFIZER INC (US) | 2011-03-08 | — | — | US | disclosed |
| US-20090312319-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | INTELLIKINE | 2009-12-17 | — | — | US | disclosed |
| US-20080146569-A1 | Nicotinamide Derivatives | PFIZER INC. | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312319-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | PIK3CA, PIK3CG, PIK3CB | CYP2C19 1585/4885PI4KA 8/4885PI4K2B 30/4885 |
| US-20080146569-A1 | Nicotinamide Derivatives | NNT, NAMPT, NADK | CYP2C19 429/4885PI4KA 3049/4885PI4K2B 3513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.